The global cryotherapy market size was valued at USD 215.52 million in 2025 and is projected to grow from USD 230.97 million in 2026 to USD 401.93 million by 2034, registering a CAGR of 7.17% during the forecast period from 2026 to 2034. North America dominated the cryotherapy market with a market share of 39.5% in 2025.
Cryotherapy, also known as cold treatment or icepack therapy, is used to destroy a range of tissue or nerve lesions and cure diseases like cervical cancer, retinoblastoma, skin cancer, and others. Cryotherapy is also known as cold treatment or icepack therapy. Patients are given ice baths in order to alleviate and relax the sections of their bodies that have been strained or damaged as a result of extended exercise, muscular sprains, or other types of tissue injury. The low temperature causes blood vessels to contract, which in turn reduces the number of inflammatory cytokines that reach that area and results in a significant increase in the intensity of the pain.
Cryotherapy treatment makes use of a variety of gases, including argon and nitrogen, among others. Cryoprobes are used to deliver liquid nitrogen directly to the targeted areas of the body in order to treat primary tumors and malignancies that are caused by cancer. Cryosurgery has a number of benefits, including that it causes less discomfort than traditional surgery, that it is performed in a less invasive manner, and that it facilitates a quicker recovery with a reduced likelihood of infection transmission.
Download a Free Sample To learn more about this report,
Whole-Body Cryotherapy Expands Across Sports and Wellness Applications
The Cryotherapy market is increasingly benefiting from the growing use of whole-body cryotherapy (WBC) in sports recovery, fitness, wellness, and rehabilitation. Athletes and fitness enthusiasts are adopting cryotherapy as part of recovery routines to address muscle soreness and support post-exercise recovery. At the same time, wellness centers, spas, and fitness facilities are adding cryotherapy chambers and cryosaunas to their service portfolios, expanding the technology beyond traditional medical settings. The growing popularity of personalized treatments is also encouraging providers to tailor cryotherapy protocols according to individual characteristics and wellness objectives.
Advanced Cryoablation and Minimally Invasive Treatments Broaden Clinical Applications
Technological advancements are expanding cryotherapy from conventional cold-treatment applications toward precision cryoablation and advanced minimally invasive procedures. Cryotherapy is increasingly used in oncology, dermatology, pain management, and other medical applications because controlled freezing can target abnormal tissue while limiting damage to surrounding areas. Improvements in cryoprobes, temperature control, imaging guidance, and treatment precision are supporting broader clinical adoption. At the same time, manufacturers are developing more compact and user-friendly systems for healthcare and wellness applications, increasing accessibility across different end users.
Technological Advancements Improve Cryotherapy Treatment Precision
Continuous technological advancements in cryotherapy equipment are making treatments more precise, efficient, and controlled, supporting market growth across medical and wellness applications. Cryochambers, cryosaunas, localized cryotherapy devices, and cryoablation systems are benefiting from improvements in temperature control, treatment monitoring, probe design, and procedure efficiency. These developments are expanding the use of cryotherapy across pain management, oncology, dermatology, sports recovery, and wellness applications.
In September 2025, AtriCure: The company launched its cryoXT™ device for post-operative pain management following amputation procedures, using its cryoICE® platform to freeze targeted nerves and block pain signals, demonstrating continued development of specialized cryotherapy technologies for clinical applications.
Growing Product Innovation Expands Cryotherapy Adoption
The introduction of new cryotherapy equipment and increasingly specialized treatment systems is creating opportunities for adoption across hospitals, specialty clinics, cryotherapy centers, spas, and fitness facilities. Manufacturers are focusing on improving treatment convenience, operating efficiency, and user experience, while expanding equipment portfolios for both medical and wellness applications. This product diversification is helping cryotherapy reach a broader customer base.
In August 2026, Channel Medsystems: The company raised $30 million in Series C financing to accelerate the commercial expansion of its Cerene® Cryotherapy platform for women with heavy menstrual bleeding and dysmenorrhea, demonstrating continued investment in specialized cryotherapy systems for medical applications.
Safety Concerns Associated with Extreme Temperatures and Cryogenic Materials
Safety considerations associated with extremely low temperatures and cryogenic materials remain a restraint for the Cryotherapy market. Improper exposure can result in cold burns, frostbite, skin damage, or other adverse effects. Medical and whole-body systems also require appropriate operating procedures, trained personnel, ventilation, equipment monitoring, and patient screening. These requirements can increase operating costs and limit adoption among smaller healthcare and wellness facilities.
In March 2025, the International Institute of Refrigeration's Whole-Body Cryostimulation Working Group: A multidisciplinary expert panel published consensus recommendations identifying temporal and absolute contraindications for whole-body cryostimulation, providing a structured safety framework for treatment providers and highlighting the importance of patient screening and controlled protocols.
Limited Clinical Evidence Restricts Wider Adoption
Although cryotherapy is established for several medical applications, evidence remains less consistent for some emerging applications, particularly certain whole-body wellness and metabolic uses. Differences in treatment temperatures, exposure duration, patient characteristics, and treatment protocols make it difficult to establish standardized approaches. Limited long-term evidence can make healthcare professionals more cautious about adopting cryotherapy for applications where clinical benefits have not been firmly established.
In September 2025, researchers at the University of Helsinki and Helsinki University Hospital: A clinical trial evaluating whole-body cryotherapy combined with conventional obesity management found no significant between-group differences in weight loss or several metabolic outcomes, underscoring the need for further clinical evidence for emerging whole-body cryotherapy applications.
Expansion of Cryotherapy Across Medical and Wellness Applications
The growing use of cryotherapy across oncology, dermatology, pain management, rehabilitation, sports recovery, and wellness is creating significant opportunities. Advances in cryoablation are enabling physicians to target abnormal tissue with greater precision, while whole-body and localized cryotherapy are being investigated for recovery and inflammatory conditions. This expanding application base can help manufacturers diversify beyond traditional cryosurgical procedures.
In September 2025, AtriCure: The company launched its cryoXT™ technology for post-operative pain management following amputation, expanding its cryotherapy platform into a new clinical application and demonstrating opportunities to diversify cryotherapy beyond traditional surgical uses.
Establishing Standardized Protocols and Demonstrating Long-Term Efficacy
A key challenge for the Cryotherapy market is establishing consistent treatment protocols and robust long-term clinical evidence across different applications. Cryotherapy can involve substantially different temperatures, exposure durations, devices, and treatment methods depending on the intended use. This variability makes it difficult to compare outcomes and establish universally accepted treatment standards. Manufacturers and healthcare providers must therefore demonstrate safety, effectiveness, appropriate patient selection, and long-term outcomes to encourage wider clinical adoption.
The Cryotherapy market is segmented based on product, application, and end user. Cryosurgery devices represent the leading product segment, supported by the increasing use of cryotherapy for minimally invasive tissue destruction and cryoablation procedures. Oncology is expected to be the fastest-growing application, driven by the expanding use of cryotherapy in targeted cancer treatment. Hospitals and specialty clinics remain the leading end users because they have the specialized infrastructure, trained professionals, and equipment required for advanced cryotherapy procedures.
Based on product, the market is segmented into Cryosurgery Devices, Tissue Contact Probes, Tissue Spray Probes, Epidermal and Subcutaneous Cryoablation Devices, Localized Cryotherapy Devices, and Cryochambers & Cryo Saunas. The Cryosurgery Devices segment dominated the market in 2025, accounting for 25.4% of the market share. These devices are widely used for controlled tissue freezing and cryoablation across oncology, dermatology, cardiology, and other surgical applications. Growing demand for minimally invasive procedures and advancements in cryosurgical equipment are supporting the segment's leading position.
Request Customizationto receive a tailored report.
Based on application, the market is segmented into Surgical Applications, Oncology, Cardiology, Dermatology, Other Surgical Applications, Pain Management, Recovery, Health, and Beauty. The Oncology segment is projected to be the fastest-growing, registering a CAGR of 9.15% from 2026 to 2034. Cryotherapy is increasingly used in targeted tumor ablation because it can destroy abnormal tissue while limiting damage to surrounding areas. Growing cancer prevalence, increasing demand for minimally invasive treatment options, and advances in image-guided cryoablation are expected to support oncology applications.
Based on end user, the market is segmented into Hospitals & Specialty Clinics, Cryotherapy Centers, and Spas & Fitness Centers. The Hospitals & Specialty Clinics segment dominated the market in 2025, accounting for 55.8% of the market share. Hospitals and specialty clinics have advanced medical infrastructure, specialized healthcare professionals, imaging capabilities, and established surgical facilities required to perform cryotherapy procedures. The increasing adoption of cryosurgery for oncology, dermatology, cardiology, and pain-management applications is further strengthening demand from these healthcare facilities.
Speak to an Analystto discuss market opportunities.
North America dominated the Cryotherapy market in 2025, accounting for 39.5% of the global market, with a market value of USD 85.13 million. The regional market is projected to grow at a CAGR of 8.45%. Growth is supported by advanced healthcare infrastructure, increasing adoption of minimally invasive procedures, rising demand for cryoablation in oncology and dermatology, and the growing popularity of whole-body cryotherapy across sports recovery and wellness applications.
The United States is a major market for cryotherapy, supported by advanced hospitals, specialty clinics, and strong adoption of innovative medical technologies. Growing cancer prevalence, increasing use of minimally invasive cryoablation procedures, and expanding applications in dermatology and pain management are supporting demand. The growing number of cryotherapy centers, wellness facilities, and sports-recovery services is also broadening the market.
Canada's Cryotherapy market is supported by improvements in specialized healthcare infrastructure and growing adoption of minimally invasive treatment technologies. Increasing demand for cryoablation in oncology and dermatology is supporting medical applications, while wellness centers and fitness facilities are creating additional demand for localized and whole-body cryotherapy.
Unlock Regional Insightsto access country-level data, & regional trends.
Europe accounted for 28.2% of the global Cryotherapy market in 2025, with a market value of USD 60.78 million. The regional market is projected to grow at a CAGR of 8.1%. Market growth is driven by the increasing adoption of minimally invasive procedures, rising cancer prevalence, established healthcare systems, and growing applications of cryotherapy in oncology, dermatology, and pain management.
Germany is supported by its advanced healthcare infrastructure and strong adoption of medical technologies. Increasing use of cryoablation for cancer treatment and growing demand for minimally invasive procedures are supporting medical applications. In addition, the expansion of specialized clinics and wellness facilities is creating opportunities for localized and whole-body cryotherapy.
The United Kingdom market is benefiting from increasing demand for minimally invasive treatment options and growing awareness of cryotherapy applications. Oncology and dermatology represent important areas of adoption, while cryotherapy is also gaining attention across sports recovery, rehabilitation, and wellness services.
Asia Pacific accounted for 21.4% of the global Cryotherapy market in 2025, with a market value of USD 46.12 million. The regional market is projected to grow at a CAGR of 10.35%, making it the fastest-growing major region. Growth is driven by expanding healthcare infrastructure, rising healthcare expenditure, increasing cancer prevalence, and growing adoption of advanced medical technologies.
Japan is supported by its advanced healthcare system, aging population, and increasing demand for minimally invasive medical procedures. Cryotherapy has opportunities across oncology, dermatology, pain management, and rehabilitation. Growing interest in sports recovery and wellness treatments is also expanding applications beyond conventional medical settings.
China is expected to experience strong growth due to its large patient population, expanding healthcare infrastructure, and increasing investment in advanced medical technologies. Rising cancer prevalence is supporting demand for minimally invasive oncology procedures, including cryoablation. Growing healthcare awareness and expansion of specialty hospitals, clinics, fitness centers, and wellness facilities are further creating opportunities for cryotherapy adoption.
Latin America accounted for 6.3% of the global Cryotherapy market in 2025, with a market value of USD 13.58 million. The regional market is projected to grow at a CAGR of 7.85%. Growth is supported by improving healthcare infrastructure, increasing awareness of minimally invasive procedures, and rising demand for advanced oncology and dermatology treatments. Expansion of private healthcare facilities and wellness centers is also supporting market development.
Brazil represents an important market in Latin America, supported by its large population and expanding healthcare sector. Increasing adoption of minimally invasive procedures and growing demand for advanced cancer treatments are supporting cryotherapy applications. The expansion of fitness, sports-recovery, and wellness facilities is also creating additional opportunities for localized and whole-body cryotherapy.
The Middle East and Africa accounted for 4.6% of the global Cryotherapy market in 2025, with a market value of USD 9.91 million. The regional market is projected to grow at a CAGR of 7.25%. Growth is supported by healthcare infrastructure development, increasing investment in advanced medical technologies, rising demand for specialized cancer treatments, and growing medical tourism.
The UAE market is supported by substantial investments in advanced healthcare infrastructure, specialty hospitals, and medical tourism. Growing demand for innovative minimally invasive treatments is supporting cryotherapy applications in oncology, dermatology, and pain management. The country's expanding luxury wellness, fitness, and sports-recovery sectors are also increasing demand for whole-body and localized cryotherapy services.
The Cryotherapy market is competitive, with key companies focusing on cryosurgery systems, cryoablation technologies, localized cryotherapy, cryotherapy chambers, specialized probes, and pain-management solutions. Market participants are investing in product development, treatment precision, portability, and improved patient comfort to expand applications across oncology, dermatology, pain management, rehabilitation, sports recovery, and wellness. Key players include Medtronic, Galil Medical, CooperSurgical, Cryotherapy, Zimmer MedizinSysteme, Metrum Cryoflex, Brymill Cryogenic Systems, Erbe Elektromedizin, CryoConcepts, and US Cryotherapy.
Metrum Cryoflex is a Poland-based medical-device manufacturer specializing in cryosurgery, cryotherapy, cryoanalgesia, physiotherapy, and related medical technologies. Established in 1992, the company has developed a broad portfolio of cryotherapy and cryosurgery equipment and currently operates across almost 55 countries on five continents, supplying hospitals, physicians, and distributors worldwide.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Breast Implants Market Size, Share, Growth, Analysis, 2034
Continuous Glucose Monitoring Systems Market Size, Share, 2034
Colposcopes Market Size, Share, Growth, Analysis, Report, 2034
Alpha Emitter Market Size, Share, Growth, Analysis, Report, 2034
Bioabsorbable Stents Market Size, Share, Growth, Analysis, 2034
Artificial Cornea and Corneal Implant Market Size, Share, 2034
We are featured on:
sales@straitsresearch.com